Table 2 Patients' Disease Courses of COVID-19 infection
Case A | Case B | Case C | Case D | Case E | ||
|---|---|---|---|---|---|---|
Presentation | Fever for 2 days, max 39.9 °C | Fever for 5 days, max 38.3 °C, with fatigue and anorexia | Fever for 2 days, max 38.5 °C, with sputum sounds | Fever for 2 days, max 39.8 °C, with dry cough, fatigue, monophagia, and myalgia | Fever for 2 days, max 38 °C | |
Injected doses of COVID-19 vaccine | 0 | 0 | 0 | 0 | 0 | |
Interval from symptom onset to RT-qPCR positive (day) | 1 | 6 | 0 | 2 | 2 | |
Length of the infection course (day) | 40 | 29 | 39 | 19 | 18 | |
Severance of COVID-19† | Mild | Mild | Moderate | Mild | Moderate | |
RT-qPCR positive duration (days) | 23 | 13 | 13 | 17 | 15 | |
Co-infection | None | None | None | EBV | HBV, TB | |
Chest radiography | Pneumonia | -§ | - | Normal | multiple calcification | |
Blood routine‡ | WBC 3.5–9.5 × 10^9/L | 4.86 | - | 1.23 | 28.39↑ | 10.26↑ |
Lymphocytes (#) 1.2–3.4 × 10^9/L | 1.61 | - | 0.19 | 2.9 | 5.7↑ | |
CRP‐max 0–8 mg/L | 9.63 | - | 16.26↑ | 3.7 | 40.78↑ | |
Liver function‡ | ALT 9–50 IU/L | 16 | - | 56↑ | 63↑ | 56↑ |
AST 15–40 U/L | 63↑ | - | 57 | 84↑ | 57 | |
γ-GT 10–60 U/L | 145↑ | - | 42 | 30 | 42 | |
FK/CSC C0 level | 197.40 | - | 7.30 | 2.30 | 52.00 | |